Cibler des niveaux d’acide urique dans le traitement de la goutte | The College of Family Physicians
of Canada Skip to main content Main menu Home Articles Current Published Ahead of Print Archive …

Best evidence finds that increasing the dosage of allopurinol to achieve a serum urate target
(eg,< 360 μmol/L) does not reduce gout flares, pain, or function compared with standard …

Il faut ajuster la dose d'hypo-uricémiant (annexe 1D) pour atteindre un taux d'urate sérique<
360 µmol/L en effectuant des contrôles tous les mois. Des taux d'urate sérique< 360 µmol/L …

Many patients with acute gout (11%-49%) have normal serum uric acid (SUA) levels
(strength of recommendation [SOR]: A, prospective cohort studies). Patients taking …

In order to support Hazard et al.'s comments, a preliminary case-control study was
performed to explore the association between the first gout attack and allopurinol use by …

In the USA, the prevalence of asymptomatic HU is 16.9% and has increased over several
decades [3, 4]. Only about half of those with serum urate concentration> 100 mg/L develop …

AIM: To establish a benchmark for gout control using the proportion of patients with serum
uric acid (SUA)< 0.36 mmol/L, assess patients' understanding of their preventive medication …

Background: The desired serum urate level (SUA) for prevention of gout attacks is widely
recommended to be in the subsaturating range,< 6.0 mg/dL. Objectives: The objectives of …

Gout is an inflammatory disease caused by the accumulation of monosodium urate crystals
in joints and soft tissues as a result of chronic hyperuricemia. 1 The prevalence of gout has …

Arthritis caused by gout (ie, gouty arthritis) accounts for millions of outpatient visits annually,
and the prevalence is increasing. Gout is caused by monosodium urate crystal deposition in …